Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

237
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
237

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacopa-enriched formulation enhances memory and synaptic plasticity in a rat model of vascular dementia.

Behavioural brain research·2026
Same author

Commentary on Zacher et al.: How cocaine memories may drive craving and drug instrumentalization.

Addiction (Abingdon, England)·2026
Same author

Vasodilatory study of Mitragyna speciosa (Korth.) Havil methanolic extract using rats aortic ring assay.

Journal of ethnopharmacology·2026
Same author

The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis.

Molecular psychiatry·2026
Same author

Dissociating role of Bassoon in glutamatergic and dopaminergic neurons in alcohol-related behaviour and affective state in mice.

British journal of pharmacology·2026
Same author

Dihydrotestosterone and Finasteride Effects on Alcohol Cue-Elicited Brain Activity in Males With Heavy Episodic Drinking.

Addiction biology·2026

Related Experiment Video

Updated: Oct 15, 2025

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.2K

Mitragynine improves cognitive performance in morphine-withdrawn rats.

Chiek Yi You1, Zurina Hassan1, Christian P Müller1,2

  • 1Centre for Drug Research, Universiti Sains Malaysia, Minden, Penang, Malaysia.

Psychopharmacology
|October 25, 2021
PubMed
Summary
This summary is machine-generated.

Mitragynine, derived from Kratom, alleviates morphine withdrawal symptoms and improves cognitive deficits in rats. This suggests its potential as a safe therapy for opiate addiction, addressing unmet medical needs.

Keywords:
Cognitive functionsKratomLearningMitragynineSubstitution therapy

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.1K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.5K

Related Experiment Videos

Last Updated: Oct 15, 2025

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.2K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.1K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.5K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Opiate addiction presents a significant unmet medical need, with current therapies like methadone potentially worsening cognitive impairments.
  • Mitragynine, a Kratom alkaloid, shows promise for opiate addiction treatment, but its health effects require further investigation.

Purpose of the Study:

  • To investigate the cognitive effects of mitragynine substitution therapy in morphine-withdrawn rats.
  • To explore the potential role of neuronal markers, including brain-derived neurotrophic factor (BDNF) and alpha-CaMKII, in mediating mitragynine's effects.

Main Methods:

  • Male Sprague-Dawley rats underwent escalating morphine doses, followed by discontinuation to induce withdrawal.
  • Subsequent treatment involved vehicle or varying doses of mitragynine (5-30 mg/kg) for three days.
  • Withdrawal signs were monitored, and cognitive functions were assessed using novel object recognition and attentional set-shifting tests.

Main Results:

  • Morphine withdrawal induced significant withdrawal signs and cognitive deficits in the attentional set-shifting test.
  • Mitragynine treatment effectively reduced withdrawal symptoms.
  • While not impacting recognition memory, mitragynine significantly improved reversal learning deficits in withdrawn rats.

Conclusions:

  • Mitragynine demonstrates efficacy in mitigating opiate withdrawal symptoms.
  • The study supports mitragynine as a potential safe therapeutic agent for opiate addiction.
  • Mitragynine shows beneficial effects on cognitive deficits associated with opiate withdrawal.